Loading...
Loading...
If you have ever received a stock option grant at a venture-backed startup, you have probably seen the phrase "strike price set at fair market value as determined by the company's most recent 409A valuation" buried in your option agreement. For most employees, that single sentence is the entire conversation about pricing. Understanding 409A valuation and stock options — how the number is set, when it changes, and what it actually means for the equity you have been granted — is the difference between a deliberate exercise decision and an expensive surprise at tax time. This guide walks through how Section 409A of the Internal Revenue Code shapes the value of your options, the 409A impact on employee stock options across different stages of your career, and what every employee should watch for when grants vest, refreshes hit, or a new funding round resets the company's price tag.
A 409A valuation is an independent appraisal of the fair market value of a private company's common stock. It exists because Section 409A of the Internal Revenue Code, introduced after the early-2000s corporate scandals, requires that stock options issued by private companies have a strike price equal to or above the fair market value of the underlying stock on the grant date. Price the strike too low and the IRS can treat the grant as deferred compensation, triggering immediate taxation, a 20% federal penalty, and additional state-level surcharges. The IRS audit techniques guide on nonqualified deferred compensation is the canonical reference for the underlying rules.
In practice, almost every venture-backed company commissions a 409A valuation from a third-party firm at least once every twelve months — and immediately after any material event, such as a priced equity round, an acquisition offer, a major customer loss, or a significant change in revenue. Companies that follow this process gain what is called the "safe harbor presumption," which shifts the burden of proof to the IRS if the valuation is ever challenged.
For employees, the headline number from any 409A report is the per-share common stock value. That number becomes the strike price on every option grant issued during the report's effective window — typically the next 12 months, or until a material event forces a refresh.
Here is where the relationship between 409A valuation and stock options gets concrete. When you join a startup, the board approves an option grant priced at the most recently determined strike. If the company's last 409A came in at $1.20 per share and you receive 40,000 options, your cost to exercise is $48,000. The 409A does not determine what your options will eventually be worth — it determines what you have to pay to convert them into actual shares.
This matters in two directions. Going up: if the company raises a Series C at a higher preferred-stock price and the next 409A reflects that, new hires will receive options at a higher strike. Your earlier grant becomes more valuable on a relative basis because your strike is "in the money" compared to the new common-stock fair market value. Going down: if revenue declines or the funding environment cools, a fresh 409A can come in lower and new hires will receive cheaper options than you did. That dynamic is one reason a 409A valuation employee with vested grants should treat each new report as material context, not background noise.
There is a tax wrinkle too. For incentive stock options (ISOs), the spread between the strike price and the 409A-derived fair market value at exercise is the input for alternative minimum tax (AMT) calculations. For nonqualified stock options (NSOs), that same spread is taxable as ordinary income at exercise. In both cases, the 409A is the number the IRS will eventually compare against, so it is worth knowing where it stands before you click "exercise." For a deeper walkthrough of the exercise decision itself, the Should I Buy My Equity? guide covers the full framework.
The 409A impact on employee stock options is not static — it shifts depending on where you are in your tenure. In my experience advising employees through more than a decade of equity events, three stages keep recurring.
Pre-vesting. When you first join, your strike price is locked in by the 409A in effect on your grant date. Even if the company's 409A doubles a quarter later, your strike does not change. This is one of the strongest arguments for joining a company earlier rather than later: not the upside narrative, but the locked-in cost basis on options that may eventually be worth far more.
Mid-tenure. This is where most employees miss the most leverage. As you continue to vest, existing tranches do not carry a new strike — they keep the original grant's strike. But additional refresher grants, performance grants, or promotion grants are issued at the current 409A. I have seen plenty of long-tenured employees with three or four separate grants at three or four separate strikes, each with very different breakeven economics.
Late tenure and pre-exit. Once a company is approaching an IPO, a direct listing, or a strategic acquisition, 409A valuations typically climb sharply and refresh more frequently. The 409A impact on employee stock options at this stage is significant: the spread at exercise can balloon, creating AMT exposure for ISO holders that may exceed an employee's available cash. Harvard Business Review has documented how this becomes the single most common late-stage equity mistake — waiting until the tender offer or IPO to think about a 409A that has been climbing for two years.
A 409A is not a one-and-done document. Companies must refresh the appraisal when any of the following happens: a priced equity round (Seed, Series A, B, C, and so on); a material acquisition offer or signed term sheet; a secondary tender offer that establishes a new common-stock price; a material change in business performance, such as a major customer win or loss, a strategic pivot, or regulatory action; or simple expiration of the prior 409A after twelve months.
For a 409A valuation employee, each refresh is a planning event. New grants will price off the new number, exercise economics shift, and tax windows open or close. Bloomberg's reporting on the 2022–2024 venture market reset is a good reminder that down rounds — and the 409A markdowns that follow them — became far more common during that period. A lower 409A can actually open a window to exercise older, higher-strike options at a smaller AMT cost than was possible at the peak.
Worth noting: the 409A common-stock value usually trails the preferred-stock round price by a meaningful discount — historically 20% to 40% — because common stock lacks the liquidation preferences, anti-dilution protections, and other rights that preferred holders negotiate. So when a TechCrunch headline announces that your company raised at a $2 billion post-money, the 409A you actually receive options at may reflect a per-share common-stock value 25% to 35% lower than the preferred-share price.
Once you understand the mechanics, the next question is what to do with the information. Three practical moves:
Track every 409A you live through. Save a spreadsheet with the dates and per-share values of each 409A that was in effect during your tenure. This is the raw data you will need at exercise time, at termination, and at tax filing. Many companies share the headline 409A through Carta, Pulley, or a similar cap-table platform; if yours does not, ask. Most will share it if you ask politely.
Model exercise scenarios at each strike. If you have multiple grants at different strikes, your cost-to-exercise math is multi-layered. The Aption Equity Simulator walks employees through the cost, the AMT exposure, and the projected outcomes at different exit scenarios. If you would rather not write a check at all, the How to Pay for Stock Options guide covers the financing options that exist for employees who hold but cannot afford to exercise.
Watch for the post-down-round window. When a company resets to a lower 409A — voluntarily or because performance dictated it — your existing in-the-money options become less valuable on a spread basis, but the AMT calculation becomes friendlier if you choose to exercise. That is an unusual moment when bad news for the company can be a planning advantage for the long-tenured employee, provided you have the cash and the conviction. The SEC's primer on employee stock options is a useful refresher on the regulatory basics before you make any move.
In my experience advising startup employees, here is the trap I see most often: people anchor their entire net-worth conversation to the most recent 409A. "We just got a fresh 409A and my options are worth $1.4 million on paper." Maybe so — but a 409A is a single point estimate of a single private company's common stock, on a single date, by a single appraiser. It is not a guarantee of liquidity, not a guarantee of price stability, and not an indicator of what you would actually receive in a sale.
The honest version of the math is that the 409A is a strike-price tool first, a tax tool second, and a wealth-planning data point a distant third. Treating it as the last of those without diversification context is how concentrated equity risk becomes wealth catastrophe. The well-worn venture reminder is that something like two-thirds of venture-backed startups never return invested capital — a power-law distribution that no individual employee can hedge with conviction alone.
This is precisely why platforms for equity pooling exist. By pooling shares across a basket of startups, employees can preserve upside exposure while smoothing out the single-name risk that a 409A does not price in. Understanding the relationship between 409A valuation and stock options is a necessary first step; pairing that understanding with portfolio thinking is what turns it into an actual plan.
If you are a 409A valuation employee trying to make smart decisions, here is the four-question checklist I give clients:
1. What is my current strike, by grant? List every grant, the grant date, and the strike from the 409A in effect at the time.
2. What is the current 409A common-stock value? Compare it to each strike. Calculate the per-share spread and the AMT or ordinary-income implications.
3. When does my next refresh likely occur? Is the company raising, approaching a 12-month anniversary, or contemplating a tender? Timing affects every exercise decision.
4. What is my concentration risk? If your startup equity is more than 20% to 30% of your liquid-and-illiquid net worth, the 409A on its own is not a strategy — diversification is.
For a thorough look at the diversification mechanisms available to employees, the Aption homepage outlines the pooling approach, and a personalized offer walks through what your specific options could look like inside a diversified pool.
A 409A valuation is one of the more misunderstood numbers in the startup equity stack. It is not your equity's market price, it is not what your shares will eventually be worth, and it is not a wealth statement. It is the strike-price input, the AMT-spread input, and, indirectly, a market signal about how the company's last appraiser viewed the business. Being deliberate about 409A valuation and stock options — about exercise timing, refresh cycles, and concentration risk — is what separates employees who realize the value of their equity from those who watch it evaporate.
If your equity has appreciated meaningfully but you do not have the liquidity to act on it — or you are carrying too much concentration risk in a single company — Aption's equity pooling model lets you trade single-name exposure for diversified portfolio exposure without forcing a binary exercise-or-walk-away decision. It is not a fit for every situation, but for many employees sitting on appreciated options, it is worth a conversation.
Disclaimer: The author name used in this article may be a pen name or pseudonym and is used for illustrative and editorial purposes only. This article is for informational purposes only and does not constitute investment, tax, or legal advice. Past performance and historical 409A trends do not guarantee future outcomes. Consult qualified professionals before making financial decisions regarding stock options, equity compensation, or any of the strategies discussed.
Daniel is a former venture capital partner and startup equity strategist with over 15 years of experience advising founders, employees, and institutional investors on equity structures, liquidity events, and portfolio construction.